Maureen Joffe to Cohort Studies
This is a "connection" page, showing publications Maureen Joffe has written about Cohort Studies.
Connection Strength
0,382
-
Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa. Cancer Immunol Res. 2023 06 02; 11(6):720-731.
Score: 0,044
-
PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients-a South African cohort study. Breast Cancer Res Treat. 2023 Aug; 200(3):337-346.
Score: 0,044
-
The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa. Breast Cancer Res Treat. 2023 Feb; 197(3):647-659.
Score: 0,043
-
Treatment guideline concordance, initiation, and abandonment in patients with non-metastatic breast cancer from the African Breast Cancer-Disparities in Outcomes (ABC-DO) cohort in sub-Saharan Africa: a prospective cohort study. Lancet Oncol. 2022 Jun; 23(6):729-738.
Score: 0,041
-
Disparities in breast cancer survival between women with and without HIV across sub-Saharan Africa (ABC-DO): a prospective, cohort study. Lancet HIV. 2022 03; 9(3):e160-e171.
Score: 0,040
-
Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa. Breast Cancer Res Treat. 2021 Aug; 189(1):285-296.
Score: 0,038
-
A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection. Breast Cancer Res Treat. 2020 Dec; 184(3):861-872.
Score: 0,036
-
A Custom Genotyping Array Reveals Population-Level Heterogeneity for the Genetic Risks of Prostate Cancer and Other Cancers in Africa. Cancer Res. 2020 07 01; 80(13):2956-2966.
Score: 0,035
-
Informal Caregiver Challenges for Advanced Cancer Patients During End-of-Life Care in Johannesburg, South Africa and Distinctions Based on Place of Death. J Pain Symptom Manage. 2018 07; 56(1):98-106.
Score: 0,031
-
Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11. Cancer Epidemiol. 2018 02; 52:120-127.
Score: 0,030